Showing results (311-320 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|May 31, 2022
AXL and MET in Hepatocellular Carcinoma: A Systematic Literature ReviewChih-Hung Hsu, Yi-Hsiang Huang, Shi-Ming Lin, et al.
Liver Cancer|May 31, 2022
Genetic Variant of CXCR1 (rs2234671) Associates with Clinical Outcome in Perihilar CholangiocarcinomaIsabella Lurje, Zoltan Czigany, Jan Bednarsch, et al.
Liver Cancer|July 9, 2021
Real-World Data on Clinical Outcomes of Patients with Liver Cancer: A Prospective Validation of the National Cancer Centre Singapore Consensus Guidelines for the Management of Hepatocellular CarcinomaXin Hui Chew, Rehena Sultana, Eshani N Mathew, et al.
Liver Cancer|July 9, 2021
Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 TrialMasatoshi Kudo, Kenta Motomura, Yoshiyuki Wada, et al.
Liver Cancer|July 9, 2021
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 TrialMasatoshi Kudo, Ho Yeong Lim, Ann-Lii Cheng, et al.
Liver Cancer|December 5, 2019
Irradiation-Related Lymphopenia for Bone Metastasis from Hepatocellular CarcinomaSangjoon Park, Hwa Kyung Byun, Jinsil Seong
Liver Cancer|December 24, 2021
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular CarcinomaPetros Fessas, Muntaha Naeem, Matthias Pinter, et al.
Liver Cancer|December 24, 2021
Associations of Serum Tumor Biomarkers with Integrated Genomic and Clinical Characteristics of Hepatocellular CarcinomaKeun Soo Ahn, Daniel R O'Brien, Yong Hoon Kim, et al.
Liver Cancer|December 24, 2021
Higher Enhancement Intrahepatic Nodules on the Hepatobiliary Phase of Gd-EOB-DTPA-Enhanced MRI as a Poor Responsive Marker of Anti-PD-1/PD-L1 Monotherapy for Unresectable Hepatocellular CarcinomaTomoko Aoki, Naoshi Nishida, Kazuomi Ueshima, et al.
Liver Cancer|February 28, 2022
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular CarcinomaKennedy Yao Yi Ng, Sze Huey Tan, Jack Jie En Tan, et al.
Pageof 55